                         SEQUENCE LISTING

<110>  CohBar Inc.
 
<120>  METHOD OF TREATING CORONAVIRUS INFECTIONS

<130>  32701/CBA075A

<150>  US 63/010,627
<151>  2020-04-15

<150>  US 63/035,537
<151>  2020-06-05

<150>  US 63/064,333
<151>  2020-08-11

<150>  US 63/122,397
<151>  2020-12-07

<150>  US 63/150,415
<151>  2021-02-17

<160>  79    

<170>  PatentIn version 3.5

<210>  1
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is absent or if present is an amino acid having a polar side 
       chain or a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is an amino acid having a polar side chain or a non-polar 
       side chain

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is absent or if present is an amino acids having a polar side
       chain or a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is absent or if present is an amino acids having a polar side
       chain or a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is absent or if present is an amino acids having a polar side
       chain or a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is an amino acid having a polar side chain or a non-polar 
       side chain

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa  is an amino acid having a polar side chain or a non-polar 
       side chain

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is an amino acid having a polar side chain

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is an amino acid having a polar side chain

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Xaa is absent or if present is an amino acid having a polar side 
       chain or a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is absent or if present is an amino acid having a polar side 
       chain or a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is absent or if present is an amino acid having a polar side 
       chain or a non-polar side chain

<400>  1

Xaa Arg Xaa Xaa Xaa Xaa Xaa Xaa Xaa Gln Xaa Leu Xaa Xaa Xaa Xaa 
1               5                   10                  15      


<210>  2
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

Met Arg Arg Ile Ile Gly Ile Val Phe Gln Cys Leu Cys Gly Leu 
1               5                   10                  15  


<210>  3
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3

Arg Arg Ile Ile Gly Ile Val Phe Gln Cys Leu Cys Gly Leu 
1               5                   10                  


<210>  4
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  4

Arg Arg Ile Ile Gly Ile Val Phe Gln Cys Leu Cys Gly 
1               5                   10              


<210>  5
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  5

Arg Arg Ile Ile Gly Ile Val Phe Gln Cys Leu Cys 
1               5                   10          


<210>  6
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  D-Ala

<400>  6

Arg Arg Ile Ile Gly Ile Val Phe Gln Cys Leu Cys Ala Leu 
1               5                   10                  


<210>  7
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  7

Met Arg Arg Met Met Gly Met Val Phe Gln Cys Leu Cys Gly Leu 
1               5                   10                  15  


<210>  8
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  8

Arg Arg Met Met Gly Met Val Phe Gln Cys Leu Cys Gly Ala 
1               5                   10                  


<210>  9
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  D-Ala

<400>  9

Arg Arg Ile Ile Ala Ile Val Phe Gln Cys Leu Cys Ala Leu 
1               5                   10                  


<210>  10
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  10

Arg Arg Met Met Gly Met Val Tyr Gln Cys Leu Cys Gly Ala 
1               5                   10                  


<210>  11
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  11

Arg Arg Met Met Gly Met Val Ala Gln Cys Leu Cys Gly Ala 
1               5                   10                  


<210>  12
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  12

Arg Arg Met Met Gly Met Val Glu Gln Cys Leu Cys Gly Ala 
1               5                   10                  


<210>  13
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  13

Arg Arg Met Met Gly Met Val Phe Gln Glu Leu Cys Gly Ala 
1               5                   10                  


<210>  14
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  14

Arg Arg Met Met Gly Met Val Phe Gln Cys Leu Glu Gly Ala 
1               5                   10                  


<210>  15
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  15

Arg Arg Met Met Gly Met Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10                  


<210>  16
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  16

Arg Arg Met Met Gly Met Val Phe Gln Cys Leu Ser Gly Ala 
1               5                   10                  


<210>  17
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  17

Arg Arg Met Met Gly Met Val Phe Gln Ser Leu Ser Gly Ala 
1               5                   10                  


<210>  18
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Norleucine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is Norleucine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Norleucine

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  18

Arg Arg Xaa Xaa Gly Xaa Val Phe Gln Cys Leu Cys Gly Ala 
1               5                   10                  


<210>  19
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  D-Ala

<400>  19

Arg Arg Met Val Phe Gln Cys Leu Cys Gly Ala 
1               5                   10      


<210>  20
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PEG12

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  d-Ala

<400>  20

Lys Arg Arg Met Met Gly Met Val Phe Gln Cys Leu Cys Gly Ala 
1               5                   10                  15  


<210>  21
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  PEG-12

<400>  21

Arg Arg Met Met Gly Met Val Phe Gln Cys Leu Cys Gly Ala Lys 
1               5                   10                  15  


<210>  22
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  D-Ala

<400>  22

Arg Arg Met Val Tyr Gln Cys Leu Cys Gly Ala 
1               5                   10      


<210>  23
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  D-Ala

<400>  23

Arg Arg Met Val Phe Gln Cys Leu Glu Gly Ala 
1               5                   10      


<210>  24
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  D-Ala

<400>  24

Arg Arg Met Val Tyr Gln Cys Leu Glu Gly Ala 
1               5                   10      


<210>  25
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  D-Ala

<400>  25

Arg Arg Glu Met Val Tyr Gln Cys Leu Cys Gly Ala 
1               5                   10          


<210>  26
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  D-Ala

<400>  26

Arg Arg Glu Met Val Tyr Gln Cys Leu Glu Gly Ala 
1               5                   10          


<210>  27
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  D-Ala

<400>  27

Arg Arg Met Ala Tyr Gln Cys Leu Glu Gly Ala 
1               5                   10      


<210>  28
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  D-Ala

<400>  28

Arg Arg Met Gly Tyr Gln Cys Leu Glu Gly Ala 
1               5                   10      


<210>  29
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  29

Arg Arg Met Met Gly Met Val Tyr Gln Cys Leu Glu Gly Ala 
1               5                   10                  


<210>  30
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  RRMMGMVAQCLEG(A

<400>  30

Arg Arg Met Met Gly Met Val Ala Gln Cys Leu Glu Gly Ala 
1               5                   10                  


<210>  31
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  D-Ala

<400>  31

Arg Arg Met Glu Val Tyr Gln Cys Leu Cys Gly Ala 
1               5                   10          


<210>  32
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  D-Ala

<400>  32

Arg Arg Met Glu Val Tyr Gln Cys Leu Glu Gly Ala 
1               5                   10          


<210>  33
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  33

Arg Arg Leu Leu Gly Leu Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10                  


<210>  34
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Aib (alpha-aminoisobutyric acid)

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  34

Arg Xaa Met Met Gly Met Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10                  


<210>  35
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Aib (alpha-aminoisobutyric acid)

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  35

Arg Xaa Leu Leu Gly Leu Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10                  


<210>  36
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PEG12

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  D-Ala

<400>  36

Lys Arg Arg Met Met Gly Met Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10                  15  


<210>  37
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PEG12

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  D-Ala

<400>  37

Lys Arg Arg Leu Leu Gly Leu Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10                  15  


<210>  38
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  38

Arg Arg Met Met Gly Met Val Glu Gln Ser Leu Cys Gly Ala 
1               5                   10                  


<210>  39
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  39

Arg Arg Met Met Gly Met Val Phe Gln Ser Leu Glu Gly Ala 
1               5                   10                  


<210>  40
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  40

Arg Arg Leu Leu Gly Leu Val Glu Gln Ser Leu Cys Gly Ala 
1               5                   10                  


<210>  41
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  41

Arg Arg Leu Leu Gly Leu Val Phe Gln Ser Leu Glu Gly Ala 
1               5                   10                  


<210>  42
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PEG12

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  D-Ala

<400>  42

Lys Arg Arg Ile Ile Gly Ile Val Phe Gln Cys Leu Cys Gly Ala 
1               5                   10                  15  


<210>  43
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  43

Arg Arg Ile Ile Gly Ile Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10                  


<210>  44
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  44

Met Met Gly Met Val 
1               5   


<210>  45
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  45

Met Met Gly Met Val Phe 
1               5       


<210>  46
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  46

Met Met Gly Met Val Phe Gln 
1               5           


<210>  47
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  47

Met Met Gly Met Val Phe Gln Ser 
1               5               


<210>  48
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  48

Met Met Gly Met Val Phe Gln Ser Leu 
1               5                   


<210>  49
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  D-Ala

<400>  49

Met Met Gly Met Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10          


<210>  50
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  50

Arg Met Met Gly Met Val Phe 
1               5           


<210>  51
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  51

Arg Met Met Gly Met Val Phe Gln 
1               5               


<210>  52
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  52

Arg Met Met Gly Met Val Phe Gln Ser 
1               5                   


<210>  53
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  53

Arg Met Met Gly Met Val Phe Gln Ser Leu 
1               5                   10  


<210>  54
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  D-Ala

<400>  54

Arg Met Met Gly Met Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10              


<210>  55
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  55

Arg Arg Met Met Gly Met 
1               5       


<210>  56
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  56

Arg Arg Met Met Gly Met Val 
1               5           


<210>  57
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  57

Arg Arg Met Met Gly Met Val Phe 
1               5               


<210>  58
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  58

Arg Arg Met Met Gly Met Val Phe Gln 
1               5                   


<210>  59
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  59

Arg Arg Met Met Gly Met Val Phe Gln Ser 
1               5                   10  


<210>  60
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  60

Arg Arg Met Met Gly Met Val Phe Gln Ser Leu 
1               5                   10      


<210>  61
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Acetyl

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  61

Arg Arg Met Met Gly Met Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10                  


<210>  62
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Amide

<400>  62

Arg Arg Met Met Gly Met Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10                  


<210>  63
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Acetyl

<220>
<221>  MISC_FEATURE
<222>  (63)..(63)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (63)..(63)
<223>  Amide

<400>  63

Arg Arg Met Met Gly Met Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10                  


<210>  64
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is absent or if present is Arg

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is absent or if present is Arg

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is absent or if present is Val

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is absent or if present is Phe. Xaa8 is absent if Xaa7 is 
       absent

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is absent or if present is Gln. Xaa9 is absent if Xaa8 is 
       absent

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is absent or if present is Ser. Xaa10 is absent if Xaa9 is 
       absent

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is absent or if present is Leu. Xaa11 is absent if Xaa10 is 
       absent

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa is absent or if present is Cys. Xaa12 is absent if Xaa11 is 
       absent

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is absent or if present is Gly. Xaa13 is absent if Xaa11 is 
       absent. Xaa13 is present if Xaa12 is present

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Xaa is absent or if present is d-Ala. Xaa14 is absent if Xaa11 is
       absent. Xaa 14 is present if Xaa13 is present

<400>  64

Xaa Xaa Met Met Gly Met Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  


<210>  65
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  65

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala 
1               5                   10      


<210>  66
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  66

Tyr Gly Arg Lys Lys Arg Arg 
1               5           


<210>  67
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  67

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210>  68
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  68

Arg Arg Gln Arg Arg 
1               5   


<210>  69
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is absent or M or K

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is R or Aib

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is absent or is -M or Nle

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is absent if Xaa3 is absent.  Xaa is M if Xaa3 is M.  Xaa is 
       Nle if Xaa3 is Nle

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is absent if Xaa3 is absent.  Xaa is G if Xaa3 is M or Nle.

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is M or Nle

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is F, A or Y

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is S, E or C

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa is E or C

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Xaa is L or dA

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is absent or K, Xaa is absent if Xaa 14 is L.

<400>  69

Xaa Xaa Xaa Xaa Xaa Xaa Val Xaa Gln Xaa Ile Xaa Gly Xaa Xaa 
1               5                   10                  15  


<210>  70
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is absent or K

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is L or I

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is L or I

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is L or I

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is S or C

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  d-Ala

<400>  70

Xaa Arg Arg Xaa Xaa Gly Xaa Val Phe Gln Xaa Leu Cys Gly Ala 
1               5                   10                  15  


<210>  71
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PEG12

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  d-Ala

<400>  71

Arg Arg Met Met Gly Met Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10                  


<210>  72
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PEG12

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  d-Ala

<400>  72

Lys Arg Arg Met Met Gly Met Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10                  15  


<210>  73
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PEG12

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  d-Ala

<400>  73

Lys Arg Arg Leu Leu Gly Leu Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10                  15  


<210>  74
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PEG12

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  d-Ala

<400>  74

Arg Arg Leu Leu Gly Leu Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10                  


<210>  75
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PEG12

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  d-Ala

<400>  75

Lys Arg Arg Ile Ile Gly Ile Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10                  15  


<210>  76
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PEG12

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  d-Ala

<400>  76

Lys Arg Arg Ile Ile Gly Ile Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10                  15  


<210>  77
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PEG12

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  d-Ala

<400>  77

Arg Arg Ile Ile Gly Ile Val Phe Gln Ser Leu Cys Gly Ala 
1               5                   10                  


<210>  78
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is absent or M or K

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is R or Aib

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is absent or M or Nle

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is absent if Xaa4 is absent; Xaa is M if Xaa4 is M.  Xaa is 
       Nle if Xaa4 is Nle

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is absent or G; Xaa is absent if Xaa4 is absent; Xaa is G if 
       Xaa4 is M or Nle.

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is M or Nle

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is F, A, or Y

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is S, E, or C

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is E or C

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is L or dA

<220>
<221>  misc_feature
<222>  (16)..(16)
<223>  Xaa is absent or K; Xaa is absent if Xaa15 is L

<400>  78

Xaa Arg Xaa Xaa Xaa Xaa Xaa Val Xaa Gln Xaa Leu Xaa Gly Xaa Xaa 
1               5                   10                  15      


<210>  79
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is absent or R

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is absent, R, or Aib. Xaa is absent if Xaa1 is absent

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is absent or V

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is absent or F; Xaa is absent if Xaa7 is absent

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is absent or Q; Xaa is absent if Xaa8 is absent

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is absent or S; Xaa is absent if Xaa9 is absent

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is absent or L; Xaa is absent if Xaa10 is absent

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa is absent or C; Xaa is absent if Xaa11 is absent

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is absent or G; Xaa is absent if Xaa11 is absent; Xaa is 
       present if Xaa12 is present

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Xaa is absent or dA; Xaa is absent if Xaa11 is absent; Xaa is 
       present if Xaa13 is present

<400>  79

Xaa Xaa Met Met Gly Met Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  


